# Porton Pharma Solutions receives $681M purchase order from Pfizer

Porton Pharma Solutions (Porton) received new purchase orders from Pfizer Ireland Pharmaceuticals, a subsidiary of Pfizer Inc., for contract development and manufacturing (CDMO) services. The total order value is $681 million, exceeding 50% of Porton's most recent audited annual revenue.

- Type: Contract
- Announced: 2022-02-11
- Value: $681.0M
- Status: completed
- Products: contract development and manufacturing (CDMO) services
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Porton Pharma Solutions](https://endata.com/companies/60990.md)
- [Pfizer](https://endata.com/companies/892.md) (customer)
- [Pfizer Ireland Pharmaceuticals](https://endata.com/companies/60991.md) (customer)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/657647.html), 2022-02-11: "新获得订单金额合计6.81亿美元，超过公司最近一个会计年度经审计营业收入的50%。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.